HLB innoVation to Hold NDR for Institutional Investors from June 1-5, Discuss Subsidiary Verismo

HLB innoVation will hold a Non-Deal Roadshow (NDR) from June 1 to 5, 2026, visiting institutional investors in Seoul.
The IR targets major domestic and foreign institutional investors, focusing on the business explanation of its subsidiary Verismo Therapeutics and Q&A.
The purpose is to enhance investor understanding and corporate value. No capital raising or new business announcement is included; it is a routine activity.
[AI Comprehensive Analysis]This disclosure is a routine IR event with no direct impact on stock price such as capital raising or management change. Investors should monitor Verismo's technology development and commercialization progress.